Besivance

Bausch + Lomb is a leading global eye health company dedicated to helping people see better to live better. The company offers a comprehensive portfolio of over 4,000 products, including contact lenses, lens care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices. One of its notable pharmaceutical products is Besivance (besifloxacin ophthalmic suspension), a fluoroquinolone antibacterial indicated for the treatment of bacterial conjunctivitis. Bausch + Lomb operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical, maintaining a significant presence in the global eye care market. The company was founded in 1853 and is currently headquartered in Vaughan, Ontario, and Bridgewater, New Jersey.